FDAnews
www.fdanews.com/articles/196906-binx-healths-std-diagnostic-earns-additional-fda-clearance

Binx Health’s STD Diagnostic Earns Additional FDA Clearance

May 1, 2020

Binx Health’s binx io molecular point-of-care testing system has received FDA clearance for detecting chlamydia and gonorrhea in men.

The system delivers lab-quality results from urine samples in approximately half an hour.

Binx previously received agency clearance in August 2019 for detecting chlamydia and gonorrhea in women.

View today's stories